ANI Pharmaceuticals initiated with a Buy at Guggenheim
The Fly

ANI Pharmaceuticals initiated with a Buy at Guggenheim

Related Articles
TheFlyANI Pharmaceuticals announces FDA approval, launch of Ketoconazole Shampoo, 2%
TheFlyANI Pharmaceuticals price target raised to $83 from $81 at Raymond James
TheFlyANI Pharmaceuticals completes acquisition of Alimera Sciences
Looking for investment ideas? Subscribe to our Smart Investor newsletter for weekly expert stock picks!
Get real-time notifications on news & analysis, curated for your stock watchlist. Download the TipRanks app today! Get the App